Highlights d Different neuroimmune signaling pathways cause neuropathic pain in males and females d Downregulation of KCC2 is equally important for pain pathogenesis in each sex d KCC2 is regulated in many ways but is uniquely responsible for regulating chloride d KCC2 is a conceptually better therapeutic target than sexspecific mechanisms
In Brief
Neuropathic pain arises in males and females through distinct neuroimmune signaling. Yet the behavioral (or clinical) features of neuropathic pain are not sexually dimorphic. Mapplebeck et al. demonstrate that KCC2-though regulated in multiple, sex-specific waysis uniquely responsible for the synaptic disinhibition causing neuropathic pain in both sexes.
SUMMARY
The behavioral features of neuropathic pain are not sexually dimorphic despite sex differences in the underlying neuroimmune signaling. This raises questions about whether neural processing is comparably altered. Here, we test whether the K + -Cl À co-transporter KCC2, which regulates synaptic inhibition, plays an equally important role in development of neuropathic pain in male and female rodents. Past studies on KCC2 tested only males. We find that inhibiting KCC2 in uninjured animals reproduces behavioral and electrophysiological features of neuropathic pain in both sexes and, consistent with equivalent injury-induced downregulation of KCC2, that counteracting chloride dysregulation reverses injury-induced behavioral and electrophysiological changes in both sexes. These findings demonstrate that KCC2 downregulation contributes equally to pain hypersensitivity in males and females. Whereas diverse (and sexually dimorphic) mechanisms regulate KCC2, regulation of intracellular chloride relies almost exclusively on KCC2. Directly targeting KCC2 thus remains a promising strategy for treatment of neuropathic pain in both sexes.
INTRODUCTION
Neuropathic pain is a chronic condition caused by damage to or dysfunction of the somatosensory system (Merskey and Bogduk, 1994) . Available treatments for neuropathic pain are largely ineffective, and the development of better ones has proved difficult despite the identification of promising drug targets (Woolf, 2010) . Sexual dimorphism in at least some mechanisms underlying neuropathic pain adds an extra dimension to this challenge (Mogil, 2012; Mapplebeck et al., 2016) .
In rodents, peripheral nerve injury (PNI) elicits persistent pain hypersensitivity to an equivalent degree in females and males but does so through distinct neuroimmune pathways (Sorge et al., 2015) . In males, activated spinal microglia (Tsuda et al., 2003) release brain-derived neurotrophic factor (BDNF), leading to downregulation of the K + -Cl À co-transporter KCC2 (Coull et al., 2005) . In mature central neurons, KCC2 extrudes Cl À from the cytosol, thus maintaining the electrochemical gradient necessary for g-aminobutyric acid A (GABA A ) and glycine receptors (GlyRs) to mediate inhibition (Kaila et al., 2014) . Downregulating KCC2 causes a depolarizing shift in the Cl À reversal potential, weakening GABA A /GlyR-mediated inhibition and causing allodynia (Coull et al., 2003; Keller et al., 2007; Prescott, 2015) . Pharmacologically enhancing KCC2 function in males restores inhibition and reduces allodynia (Gagnon et al., 2013) . Because of the sex bias in preclinical research, it was assumed (but untested) that microglia played an equally important role in female rodents. However, adaptive immune cells, rather than microglia, appear to mediate neuropathic pain in females (Sorge et al., 2015; Mapplebeck et al., 2016 Mapplebeck et al., , 2018 . Whether KCC2 downregulation contributes to neuropathic pain in females has yet to be explored.
The ability of distinct cells to produce equivalent changes in pain sensitivity constitutes degeneracy. A process or state is said to be degenerate when its basis is non-unique (Edelman and Gally, 2001) . In the context of pain processing, the basis for primary afferent neuron hyperexcitability has been shown to be degenerate (Ratté et al., 2014) , which has important implications for how to therapeutically modulate excitability (Ratté and Prescott, 2016) . In general, therapies that target one component of a degenerate system are unlikely to be successful, because changes in other (untargeted) components can circumvent the therapeutic effect. KCC2 can be regulated in many ways (Doyon et al., 2016) , which is to say that KCC2 regulation is degenerate. But as one of the only Cl À co-transporters expressed in mature central neurons, Cl À regulation (and the synaptic inhibition that depends on it) is reliant on KCC2. In other words, regulation of intracellular Cl À by KCC2 is less degenerate than regulation of KCC2, which has important implications for drug targeting.
The revelation that the neuroimmune basis for neuropathic pain is sexually dimorphic raises concerns about whether the neural changes underlying neuropathic pain also differ between males and females. However, because the behavioral phenotype is indistinguishable between male and female rodents-just as clinical features do not systematically differ between male and female patients-we hypothesized that different signaling pathways re-converge such that KCC2-mediated Cl À regulation is disrupted in both sexes. Through a combination of in vivo electrophysiology, quantitative immunohistochemistry, and behavioral pharmacology, we demonstrate that KCC2 downregulation mediates neuropathic pain in both sexes.
RESULTS

KCC2 Blockade In Vivo Disinhibits Spinal Dorsal Horn Neurons in Females and Males
Reduced inhibition in the spinal dorsal horn, whether by downregulation of KCC2 or reduced GABA A /GlyR activation, is thought to cause mechanical allodynia by allowing low-threshold (innocuous) mechanosensory input to activate projection neurons that normally respond exclusively to high-threshold (noxious) input (Coull et al., 2003; Keller et al., 2007; Lavertu et al., 2014) . Those findings were from experiments conducted exclusively in male rodents. To determine whether spinal processing is equally reliant on KCC2-dependent inhibition in females, we recorded extracellularly from superficial dorsal horn neurons in vivo in male and female rats during innocuous brush stimulation of the ipsilateral hindpaw. Superficial dorsal horn neurons, which were typically silent in the absence of stimulation, yielded brush-evoked firing rates that were comparable between sexes (Figures 1A and 1B) . Intrathecal application of the KCC2 blocker VU0240511 (VU) significantly increased brush-evoked spiking in male and female rats (Figures 1A and 1B) . Acetazolamide (ACTZ), which mitigates disinhibition caused by Cl À dysregulation (Lee and Prescott, 2015) by decreasing efflux of bicarbonate through GABA A and GlyRs by blocking carbonic anhydrase, reversed the increase in spiking caused by VU in both sexes (Figures 1A and 1B) . We conclude that synaptic inhibition in the dorsal horn depends on KCC2 in both sexes.
Attenuating Disinhibition Caused by Cl À Dysregulation Reverses SNL-Induced Hyperexcitability in Males and Females Next, we tested whether spinal nerve ligation (SNL) causes Cl À dysregulation in female neurons by assessing whether intrathecal ACTZ attenuates SNL-induced hyperexcitability. In both female and male rats with SNL, intrathecal ACTZ significantly reduced the spiking evoked by brush (dynamic) stimulation (Figures 1C and 1D) and von Frey (static) stimulation (Figures 1E and 1F) . For both stimuli, ACTZ restored normal spiking (i.e., reduced evoked firing rates to levels observed in uninjured animals), and this effect did not differ significantly between sexes. Because ACTZ selectively mitigates disinhibition caused by Cl À dysregulation, its efficacy in both male and female rats argues that nerve injury compromises Cl À regulation in both sexes.
Dorsal Horn KCC2 Is Equivalently Reduced in Males and Females after SNI
To determine whether KCC2 levels are altered in females after nerve injury, we performed quantitative immunohistochemical analysis of KCC2 protein on spinal cord sections of CD-1 mice, as used previously (Sorge et al., 2015) . IB4 and KCC2 staining was measured ipsilateral and contralateral to the side of spared nerve injury (SNI) and ipsilateral to sham injury ( Figure 2A ). IB4 labels a subset of C fibers, and its loss identifies the central termination zone of injured afferents. IB4 staining was significantly decreased in a localized area ipsilateral to SNI in both sexes ( Figure 2B ). Total cell number, as reflected by DAPI staining, did not change after SNI in CD-1 or C57BL/6 mice of either sex ( Figure S1 ). Focusing on the area with decreased IB4 staining, KCC2 was reduced ipsilaterally in both sexes ( Figure 2C ). KCC2 expression was similarly reduced in nerve-injured male and female C57BL/6N mice ( Figure 2D ), demonstrating that KCC2 downregulation is consistent across mouse strains. Intrathecal injection of the chloride extrusion enhancer CLP290 in nerve-injured female mice increased membrane KCC2 expression ( Figure S2 ), similar to what has been observed in males (Ferrini et al., 2017) . Overall, we conclude that in female mice, as in males, nerve injury reduces KCC2 expression and CLP290 rescues KCC2 membrane expression.
KCC2 Dysregulation Mediates SNI-Induced Allodynia in Females and Males
Pharmacological rescue of KCC2 downregulation restores Cl À homeostasis but does not increase inhibition above normal levels, and attenuation of allodynia by enhancers of Cl À extrusion, like CLP290, therefore implies that allodynia is caused by KCC2 downregulation (Gagnon et al., 2013) . But CLP290 has not previously been tested in females. In nerve-injured (SNI) mice, intrathecal injection of CLP290 increased withdrawal threshold in both males and females ( Figures 3A and 3B ) without causing motor impairment ( Figure S3 ). Behavioral experiments in male and female SNI rats yielded comparable results (Figures 3C and 3D) . The anti-allodynic effect of CLP290 was shorter than previously observed (Gagnon et al., 2013) , but we applied CLP290 intrathecally, whereas Gagnon and colleagues administered it systemically.
KCC2 Blockade and BDNF Elicit Allodynia in Naive Females and Males
Having demonstrated that KCC2 downregulation is necessary for neuropathic pain in male and female mice, we next investigated whether KCC2 blockade is sufficient to cause pain hypersensitivity in mice of either sex. Intrathecal application of KCC2 inhibitor DIOA induced allodynia in naive mice, regardless of sex ( Figures 4A and 4B) , thus demonstrating the sufficiency of KCC2 blockade to cause allodynia, consistent with electrophysiological data in Figures 1A and 1B . Sorge et al. (2015) demonstrated that BDNF is not necessary for the development of allodynia in female rodents, but it remains unclear whether BDNF is sufficient to cause allodynia in females, as previously demonstrated in males (Coull et al., 2005) . We found that intrathecal BDNF caused allodynia in both female and male mice ( Figures 4C and 4D) , thus demonstrating the sufficiency of BDNF to cause allodynia.
DISCUSSION
Cl À dysregulation in dorsal horn neurons has been identified as a critical mediator of neuropathic pain in male rodents. Nerve injury drives KCC2 downregulation via microglia-derived BDNF (Coull et al., 2005; Gagnon et al., 2013) , thereby dysregulating Cl À and compromising synaptic inhibition (Coull et al., 2003) . But subsequent work demonstrated that neither microglia nor BDNF is necessary for neuropathic pain in females, despite pain hypersensitivity being phenotypically indistinguishable between the sexes (Sorge et al., 2015; Mapplebeck et al., 2016) . That is, although pain hypersensitivity is quantitatively similar, the neuroimmune signaling pathways driving this in males are distinct from those in females. Whether the sexual dimorphism extends to KCC2 was hitherto untested. In the present study, we find that KCC2 downregulation and the ensuing Cl À dysregulation contribute to neuropathic pain in both sexes. Thus, despite qualitative sex differences in neuroimmune signaling after nerve injury, neurons in males and females ultimately experience a similar reduction in K + -Cl À co-transporter function, leading to comparable levels of pain hypersensitivity. Our data imply that pain hypersensitivity is degenerate insofar as multiple, distinct cellular pathways drive the downregulation of KCC2, yet KCC2 downregulation is uniquely responsible for the chloride dysregulation causing disinhibition associated with neuropathic pain.
We found that KCC2 blockade causes elevated spiking in spinal neurons and allodynia in naive female and male mice. Conversely, pharmacologically restoring GABA A /GlyR-mediated inhibition in nerve-injured rodents reverses the elevated spiking (B) Brush-evoked firing rates in naive rats. All neurons (n = 22 neurons from 3 male rats, 15 neurons from 3 female rats) were tested at baseline and with both drugs. Firing rate was not significantly affected by sex, and there was no interaction between sex and drug condition, but drug condition did have a significant effect (twoway repeated-measures ANOVA, F 2,107 = 13.10, p < 0.001). Specifically, VU significantly increased spiking in both sexes (Student-Newman-Keuls tests, males p < 0.001, females p < 0.05), and ACTZ significantly reversed that effect in both sexes (males p < 0.01, females p < 0.05). (C) Sample brush-evoked responses for a typical neuron recorded from a nerve-injured (SNL) male rat (blue) or nerve-injured female rat (pink). (D) Brush-evoked firing rates in SNL rats. All neurons (n = 16 neurons from 3 male rats, 23 neurons from 3 female rats) were tested at baseline and after ACTZ. Firing rate was not significantly affected by sex, and there was no interaction between sex and drug condition, but drug condition did have a significant effect (two-way repeated-measures ANOVA, F 1,77 = 50.58, p < 0.001). Specifically, 10 mM ACTZ significantly reduced spiking in both sexes (Student-Newman-Keuls tests, males p < 0.001, females p < 0.001). (E) Subset of cells from nerve-injured animals tested with brush stimulation were re-tested with von Frey stimulation (n = 10 cells from 2 male rats, 19 cells from 2 female rats). 2, 6, and 10 g of von Frey filaments were applied before and after application of 10 mM ACTZ. (F) As for brush stimulation, firing rates evoked by 10 g of von Frey stimulation were not significantly affected by sex, and there was no interaction between sex and drug condition, but drug condition did have a significant effect (two-way repeated-measures ANOVA, F 1,57 = 17.74, p < 0.001). Specifically, 10 mM ACTZ significantly reduced spiking in both sexes (Student-Newman-Keuls tests, males p < 0.01, females p < 0.01). All data are shown as mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Distributions of data were confirmed to be Gaussian using the Shapiro-Wilk test. and allodynia in both males and females. Quantitative immunohistochemical analysis of spinal cord slices revealed that PNI causes KCC2 downregulation in the dorsal horn of both sexes. Conversely, application of CLP290, a drug that rescues plasma membrane expression of KCC2, alleviates allodynia in both males and females and restores KCC2 membrane expression in female neurons, consistent with past findings in males. Collectively, our data demonstrate that KCC2-dependent Cl À regulation is disrupted by nerve injury and leads to neuropathic pain in both sexes.
In males, KCC2 downregulation after nerve injury depends on microglial-derived BDNF (Coull et al., 2005; Gagnon et al., 2013) . Because BDNF signaling is unnecessary for PNI-induced allodynia in females (Sorge et al., 2015) , a BDNF-independent KCC2 regulation mechanism must exist. This mechanism could involve activation of TrkB receptors or otherwise engage the downstream signaling involved in KCC2 expression, namely, phospholipase Cg and Shc (Rivera et al., 2004) ; alternatively, KCC2 downregulation could reflect the post-translational consequences of phosphorylation (B) IB4 average intensity in the area of interest was significantly reduced ipsilaterally versus contralaterally in male and female CD-1 mice with SNI (two-way repeated-measures ANOVA, F 1,13 = 42.48, p < 0.0001; Holm-Sidak test, males p < 0.001, females p < 0.001). Likewise, when comparing changes ipsilaterally in injured versus sham animals, IB4 staining was significantly decreased (two-way ANOVA, F 1,27 = 13.79, p < 0.001; Holm-Sidak test, males p < 0.05, females p < 0.05). In contrast, DAPI intensity was unchanged (see Figure S1 ), consistent with no loss of spinal neurons. (C) SNI caused downregulation of KCC2 ipsilaterally versus contralaterally in male and female CD-1 mice (two-way repeated-measures ANOVA, F 1,13 = 27.87, p < 0.001; Holm-Sidak test, males p < 0.01, females p < 0.01). Similarly, KCC2 expression was lower after SNI compared with sham (two-way ANOVA, F 1,27 = 11.75, p < 0.01; Holm-Sidak test, males p = 0.061, females p < 0.05). (D) SNI also caused downregulation of KCC2 ipsilaterally versus contralaterally in male and female C57BL/6N mice (two-way repeated-measures ANOVA, F 1,11 = 24.49, p < 0.001; Holm-Sidak test, males p < 0.05, females p < 0.01). Similarly, KCC2 expression was lower after SNI compared with sham surgery (two-way ANOVA, F 1,20 = 51.29, p < 0.0001; Holm-Sidak test, males p < 0.001, females p < 0.0001). In all analyses of IB4 and KCC2 expression, there was no effect of sex and no sex by condition interaction. Scale bar, 100 mm. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Intensity units (IUs) are shown as mean ± SEM; individual points (mice) are also plotted. CD-1: n = 9 male mice and 6 female mice with SNI, and n = 8 male mice and 8 female mice with sham. C57BL/6N: n = 6 male mice and 7 female mice with SNI, and n = 5 male mice and 6 female mice with sham. Data were averaged within each mouse based on analysis of 4-6 spinal sections per mouse. See also Figures S1 and S2. (Kahle et al., 2013; Doyon et al., 2016) . Release of pro-inflammatory mediators could also regulate KCC2 expression in females. We found that BDNF is sufficient to cause allodynia in naive female mice. Although the onset of the hypersensitivity induced by BDNF in females might have been slightly delayed in comparison with males, our findings suggest that KCC2 can be regulated in more than one way in females. Pain signaling in females appears to normally involve the adaptive immune system rather than microglia (Sorge et al., 2015; Lopes et al., 2017) , which suggests that these immune cells could be targeted to treat chronic pain in women. But in the absence of adaptive immune cells, females use the glial-dependent mechanism (Sorge et al., 2015) , which would likely undermine the efficacy of any drugs targeting adaptive immune cells. This switching supports that the pathways regulating KCC2 are degenerate.
Degeneracy is typically overlooked in pain research, despite attracting attention in other complex diseases like cancer (Ratté et al., 2014) . Degeneracy has important therapeutic implications: if more than one mechanism is sufficient to cause pathology, then no single mechanism is uniquely necessary and therapies therefore must target multiple mechanisms to be effective (Ratté et al., 2014; Ratté and Prescott, 2016) . Alternatively, drugs should target non-degenerate mechanisms. In that respect, KCC2 remains a preferable target insofar as it not only represents the sole Cl À extrusion mechanism used by most mature central neurons (Kaila et al., 2014) but also represents a final common target of degenerate signaling pathways causing neuropathic pain. Failure to consider degeneracy in pathological pain may help explain why treatments that work in controlled preclinical settings ultimately fail in clinical settings where additional (uncontrolled and unanticipated) mechanisms may come into play. In other words, the therapeutic effect of a drug acting on one pathway may be circumvented by changes in a parallel pathway. Because KCC2 expression is regulated by many pathways (Doyon et al., 2016; Mahadevan et al., 2017) , diverse alternative mechanisms could maintain KCC2 downregulation after PNI even if the default pathways (i.e., microglial or adaptive immune cell mediated) were pharmacologically suppressed. However, because KCC2 downregulation is uniquely responsible for chloride dysregulation, which contributes to the maintenance of pain hypersensitivity, therapeutics that target KCC2 function, rather than targeting one of its many regulatory pathways, would overcome the issue of degeneracy in pain signaling. Our findings suggest that KCC2 represents an excellent drug target for treatment of chronic pain in both sexes.
Targeting KCC2 in human clinical populations may become feasible given the development of the orally bioavailable KCC2 activator, CLP290 (Gagnon et al., 2013) . CLP290 directly restores KCC2 expression levels, unlike other drugs used preclinically, such as ACTZ, which mitigate the effects of chloride dysregulation by reducing bicarbonate efflux. CLP290 produces analgesia in animal models of pain equivalent to that of pregabalin (Gagnon et al., 2013) , and here we observed no sex difference 
. Chloride Extrusion Enhancer CLP290 Alleviates SNI-Induced Allodynia in Male and Female Rodents
(A) Male and female CD-1 mice were treated with CLP290 (80 mg) after SNI. 50% withdrawal thresholds were assessed at baseline (before SNI surgery), 14 days after SNI, and 15, 30, 45, 60, 90, and 120 min after drug injection (CLP290 or vehicle, n = 8-9 mice/sex/drug/time point). (B) CLP290 reversed allodynia (analyzed as the percentage of anti-allodynia) in female and male mice (two-way ANOVA, F 1,29 = 40.66, p < 0.0001; Holm-Sidak test, males p < 0.001, females p < 0.001). There was no sex difference in the impact of CLP290 on withdrawal threshold after nerve injury or interaction between sex and drug. (C) Male and female rats treated with CLP290 (300 mg) after SNI. 50% withdrawal thresholds at baseline (before SNI), 14 days after SNI, and 15, 30, 45, 60, 90, and 120 min after drug injection (CLP290 or vehicle, n = 7-8 rats/sex/drug/time point). (D) CLP290 reversed allodynia (analyzed as the percentages of anti-allodynia) in female and male rats (two-way ANOVA, F 1,27 = 101.57, p < 0.0001; Holm-Sidak test, males p < 0.0001, females p < 0.0001). There was no sex difference in effect of CLP290 on withdrawal thresholds and no interaction between sex and drug. All data are shown as mean ± SEM. *p < 0.05; ***p < 0.001; ****p < 0.0001. See also Figure S3 . in its efficacy. Unlike pregabalin, CLP290 does not produce motor impairment (Gagnon et al., 2013) . Although the pharmacokinetics of CLP290 limit its clinical utility, longer-lasting compounds that target KCC2 could have significant therapeutic potential. KCC2 expression is centrally restricted (Kaila et al., 2014) ; thus, drugs targeting KCC2 will not produce adverse effects from action on peripheral targets. Peripherally mediated side effects are a significant issue in chronic pain therapeutics, most prominently opioid-induced bowel dysfunction (Kurz and Sessler, 2003) . Altogether, Cl À extrusion enhancers represent a potential safe treatment for chronic pain that appears to target the disease process at a point that is non-degenerate.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All procedures were performed in accordance with guidelines from the Canadian Council on Animal Care and were approved by the Animal Care Committee at The Hospital for Sick Children and the CERVO Brain Research Centre. Healthy, test naive adult male and female CD-1 and C57BL6N mice (7-12 weeks old) as well as Sprague Dawley rats (8-12 weeks old) were obtained from Charles River Laboratories (Boucherville, QC). Certain CD-1 mice were bred in-house from breeding pairs from Charles River. Mice and rats were housed in same-sex polycarbonate cages with ad libitum access to food and water. Rodent housing rooms were temperature and humidity controlled with a 14:10h light:dark cycle. Littermates were randomly assigned to experimental groups. REAGENT 
METHOD DETAILS Surgery
Spinal nerve ligation The spinal nerve ligation (SNL) model (Kim and Chung, 1992 ) was used to induce neuropathic pain in rats for electrophysiology experiments. Briefly, 2-5 days before terminal experiments, the rat was anesthetized with isoflurane anesthesia (4% for induction; 2.5% for maintenance) and the paraspinal muscles of the lower lumbar and sacral level were separated to access the L6 process. The L6 process was carefully removed and the L5 spinal nerve was tightly ligated with 6-0 silk suture. All nerve-injured animals maintained motor function but developed neuropathic pain as inferred by guarding of the affected paw.
Spared Nerve Injury
The spared nerve injury (H) model (Decosterd and Woolf, 2000) was used to produce neuropathic pain in mice and rats for behavioral and immunohistochemistry experiments. Briefly, 14 days before terminal experiments, rodents were anesthetized with isofluorane anesthesia (4% for induction; 2.5% for maintenance), and the biceps femoris muscle was bluntly dissected to expose the sciatic nerve. The common peroneal and tibial nerves were ligated and lesioned, leaving the sural nerve intact. Sham surgery, performing all components of SNI surgery with the exception of sciatic nerve ligation, was conducted as a control for SNI surgery in immunohistochemistry experiments.
In vivo Electrophysiology Sprague Dawley rats (350-450 g) were anesthetized with urethane (20% in normal saline; 1.2 g/kg i.p.). We used rats in these experiments because they are amenable to multielectrode recordings in vivo. Rats were either naive or received SNL (see above). A laminectomy was performed to expose L4-S1 segments of the spinal cord. The rat was placed in a stereotaxic frame with its vertebrae clamped above and below the recording site to immobilize the spinal cord. The left hind paw was immobilized in plasticine with the plantar surface facing upward for stimulation. Rectal temperature was kept at 37 C using a feedback-controlled heating pad (TR-200, Fine Science Tools). Electrophysiology A four-electrode array with a total of 16 recording sites (A4 type, NeuroNexus) was implanted at the L5 spinal level. Electrode depth was monitored relative to the dorsal surface of the cord. Brush stimulation was applied to the hind paw to identify neurons responsive to low threshold mechanical input. The signal was amplified, band-pass filtered between 500 Hz and 10 kHz, and digitized at 20 kHz with an Omniplex Data Acquisition System (Plexon) and stored with stimulus markers on disk. Single units were isolated using Offline Sorter V3 software (Plexon), and were analyzed with Neuroexplorer 4 (Plexon).
Drug application
Using petroleum jelly, a well was built around the spinal cord to target drug delivery to the recording site. In each experiment, 200 ml of saline containing drug was delivered into the well through a small tube (OD: 0.016 inch; Cole-Palmer) inserted intrathecally. To block KCC2, VU0240551 (VU; Tocris Bioscience) was diluted in a stock solution of dimethyl sulphoxide (DMSO) and then diluted in buffered saline for a final concentration of 50 mM (Lavertu et al., 2014) . Acetazolamine (ACTZ; Sigma-Aldrich) was dissolved in buffered saline with pH 8.2; after dissolving ACTZ, pH was reduced to 7.4 and concentration was adjusted to 10 mM (Asiedu et al., 2010) .
Mechanical stimulation
Cutaneous receptive fields (RFs) were identified from spiking evoked by mechanical stimuli applied by brush or von Frey (VF) filaments to the glabrous skin of the left hind paw. Each stimulus comprised ten 1 s-long applications of the brush or VF filament (2, 6, and 10 g) repeated at 2 s intervals. Each stimulus was applied twice onto different locations within the receptive field for each test condition. To quantify the spiking evoked by mechanical stimulation, we measured the mean firing rate during each stimulus, subtracted the spontaneous firing rate measured from the 10 s epoch preceding each stimulus, and then averaged across the two stimuli for each test condition.
Quantitative immunohistochemistry
Mice were anaesthetized with intraperitoneal injections of ketamine/xylazine (10 mg/mL, 1.0 mL/50 g weight). Animals were perfused transcardially with 4% paraformaldehyde in 0.1 M PB (pH 7.4) for 15 min. Spinal cord segments L4-L5 were collected and post-fixed for 60 min in 4% paraformaldehyde in 0.1 M PB (pH 7.4) and cryoprotected in 30% sucrose in 0.1 M PB overnight at 4 C. Lumbar spinal cords were processed blind for sex and surgery type. Transverse sections were cut at 35 mm on a sledge freezing microtome Leica SM2000R (Leica Microsystems). Sections were permeabilized in PBS (pH = 7.4) with 0.2% Triton (PBS+T) for 10 min, washed twice in PBS and incubated for 12 h at 4 C in primary anti-KCC2 antibody (see below) diluted in PBS+T containing 10% normal goat serum. After washing in PBS, the tissue was incubated for 2 h at room temperature in a solution containing a mixture of the goat-Cy3 anti-rabbit purified secondary antibody (1:500; Jackson ImmunoResearch Laboratories Inc., catalog#111-165-144), DAPI and IB4 (see below) diluted in PBS+T (pH 7.4) containing 10% normal goat serum. In the immunohistochemical analysis of KCC2 expression after intrathecal CLP290, KCC2 and IB4 were co-stained with NeuN (1:1000, EMD Millipore; catalog #ABN91) instead of DAPI for confocal imaging (detected by goat-Alexa647 anti-chicken purified secondary antibody, 1:500; Thermo Fisher Scientific catalog# A-21449). Sections were mounted on superfrost gelatin-subbed slides (Fisherbrand), allowed to dry overnight at 4 C and coverslipped using fluorescence mounting medium (Dako, catalog#S3023).
A polyclonal IgG anti-KCC2 antibody was used for this study (1:1000, Millipore-Upstate, catalog #07-432). DAPI (1:500, Thermo-Fisher Scientific; catalog #D1306) was used as a control marker in the superficial dorsal horn. IB4 (Alexa Fluor 488-conjugated IB4, 1:500, Invitrogen, catalog #I21411) staining was used to identify superficial dorsal horn and lesion in SNI mice in the L4-L5 lumbar segments.
During image acquisition, the experimenter was blind to sex of the mouse spinal cord. Images were obtained with a Nikon Eclipse Te2000-U epifluorescent microscope and a 20X plan-apochromatic air objective (NA 1.4) using dichroic filter 350/488/543, equipped with a Cool-Snap HQ camera and an X-Cite series 120Q lamp (EXFO). Metamorph software (version 7.8) was used for image acquisition. Each fluorophore was imaged sequentially to minimize channel bleed through and different emission filters (Chroma) were used for different fluorophores (UV-2A for DAPI, 510IF for Alexa 488, HYQ for Cy3). Images of 12-bits were taken, 1040x1392 pixels pictures with pixel resolution of 0.503 mm. In spinal cord sections, KCC2 pixel intensity in the white matter (which does not express KCC2) was defined as the averaged KCC2 background noise and was subtracted from the averaged KCC2 pixel intensity measured in superficial dorsal horn using ImageJ (1.47 version) (Coull et al., 2003) . Background noise of IB4 was defined as pixel intensity located in the deep dorsal horn (region without expression). Loss of IB4 staining was used to define the region of interest analyzed in SNI mice. Corresponding contralateral regions were used as an internal control in each SNI mouse. Dorsal horn pictures in sham mice were taken in the same rostro-caudal and lateral regions of the dorsal horn spinal cords for comparison to SNI.
Confocal laser scanning microscopy
All confocal images were acquired using a Zeiss LSM 880 Confocal Laser Scanning Microscope equipped with an oil-immersion x63 plan-apochromatic (Numerical Aperture 1.4) objective. Acquisitions were 12-bit images of size 1352x1352 pixels with a pixel dwell time of 3.1 ms and a pixel resolution of 0.1 mm. Loss of IB4 staining in the ipsilateral side was used to define the region of interest analyzed in SNI mice. Laser power was chosen to avoid saturation and limit photobleaching. All the acquisitions were performed with the same laser settings (laser, power, photomultiplier tube (PMT) settings, image size, pixel size and scanning time). During the acquisitions, the experimenter was blind to the slice conditions (i.e., vehicle versus CLP290 treatment).
Membrane KCC2 index analysis
As previously shown (Ferrini et al., 2017) , the spinal dorsal horn (SDH) corresponds to a dense neuronal network in which the majority of single neurons cannot be clearly separated or delineated. For this analysis, an index was defined that reflects the global membrane KCC2 intensity, and was not based on manual selection of large, easy to delineate cell bodies ( Figure S2A ). Fiji-ImageJ 64-bits (1.52i version) was used to discriminate the KCC2 membrane population from the KCC2 intracellular population in the SDH. For each image of an immunostained section, the average non-specific staining level quantified in isolated white matter regions was subtracted from the whole image. The intensity of the intracellular KCC2 immunostaining was then defined in regions of NeuN-positive neurons of the SDH. Finally, the averaged KCC2 pixel intensity was calculated within the loss of IB4 terminals (total KCC2 staining in pink rectangle, Figure S2A ). To obtain the membrane KCC2 intensity per pixel, the average intracellular KCC2 pixel intensity value was subtracted from the average KCC2 pixel intensity in the region defined by IB4 loss. The overall membrane KCC2 intensity index per mouse was measured by averaging the values of four to six spinal cord sections (n = 5 mice with vehicle, n = 6 mice with CLP290).
Drug administration
Intrathecal injections were conducted using a 30 gauge, 1/2 inch needle inserted between the L5 and L6 vertebrae using light restraint in mice and under brief isofluorane/oxygen anesthesia (2.5%) in rats (Hylden and Wilcox, 1980) . CLP290 was dissolved using a bath sonicator in 20% 2-hydroxypropyl-b-cyclodextrin to a final concentration of 10 mg/ml (Gagnon et al., 2013) . CLP290 was administered intrathecally following post-surgical behavioral measurements. In mice, 80 mg CLP290 was administered in a volume of 8 mL. In rats, 300 mg CLP290 was administered in a volume of 30 mL. R-(+)-DIOA was purchased from Sigma and 2.0 mg was intrathecally administered in naive mice in a volume of 5 mL (dissolved in 10% DMSO). Human recombinant BDNF (0.5 mg, i.t.) was obtained from Alomone and intrathecally injected in naive mice in a volume of 5 mL (dissolved in 10% DMSO).
Behavioral Testing
Rodents were placed in plastic cubicles on a perforated metal platform and habituated for 30 min (rat) or 60 min (mice) before behavioral testing. For assessment of pain behavior, the 50% mechanical withdrawal threshold was calculated using the up-down method of Dixon (Chaplan et al., 1994) . In CLP290 behavioral experiments, calibrated nylon monofilaments were applied for 1 s to the lateral aspect of the ipsilateral hindpaw to induce a withdrawal response. Pre-and post-surgical (14 days after nerve injury) values constitute the average of two measurements taken 15 min apart. Post drug values are a single measurement taken at 15, 30, 45, 60, 90, 120 min after intrathecal CLP290. Motor performance was assessed with an accelerating rotarod after administration of CLP290. Time on the rotarod was measured twice at each 30, 45 and 60 min post injection (time points of highest drug efficacy). Final rotarod values constitute the average of the 6 data points obtained over the entire testing period. DIOA and BDNF experiments were conducted as described above for CLP290, but using naive mice. For DIOA, post drug values were single measurements taken at 15, 20, 45, 60, 120 min after injection. For BDNF, post drug values constitute the average of two measurements at 60, 120, 180, 240 mins after injection.
